BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BCC Research Publishes New Report On Global Circulating Tumor Cell Technologies Market


1/30/2014 9:24:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Wellesley, MA (PRWEB) January 30, 2014 -- According to a new technical market research report Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets, from BCC Research (http://www.bccresearch.com), the global market for circulating tumor cell technologies was valued at nearly $2.8 billion in 2012 and $3.7 billion in 2013. BCC Research projects the market to grow to nearly $8.9 billion by 2018, and register a five-year compound annual growth rate of 18.9% from 2013 to 2018.

Circulating tumor cells are cancer cells that separate from the primary tumor and circulate in the peripheral blood, with the potential for growth of additional tumors (metastasis) in distant vital organs. Significant progress is being made in the development of technologies for the detection, characterization, and analysis of these cells. In fact, CTC technologies remain one of the most promising areas of cancer research for guiding patient treatment and predicting cancer progression.

Currently used detection methods lack sensitivity or specificity to track all circulating tumor cells, particularly the ones that have lost characteristic epithelial features. In addition to advantages such as high sensitivity and specificity, CTC technologies offer reproducible, repeatable, and non-invasive diagnostic assays for guiding treatment decision and improved patient triage.

The rising prevalence of diseases like cancer and the reimbursement support by regulatory bodies in developed regions such as the United States and Europe are the major factors driving the growth of the CTCs market. Increasing R&D spending, technological advancements, and rising numbers of cancer patients will also drive tremendous growth for the foreseeable future.

This report from BCC Research focuses on circulating tumor cell testing and monitoring methods, and includes an overview on cancer, diagnostic strategies, and treatment technologies. Important trends in the field of cancer research and development are reviewed and sales forecasts by treatment and screening categories are provided from 2013 through 2018. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics, and other factors that directly affect the circulating tumor cell market.

In addition, the report provides a comprehensive review of cancer, incidence and development of the disease, drugs currently being used, and diagnostic technologies. It also reviews technological developments, product innovations/introductions, and recent strategic industry activity of major players across various product categories. Growth rates, global incidence, and projections were determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in R&D, and current product growth, etc. Forecasts and projections were based on estimates such as the current trends, potential users, mergers and acquisitions, and market trends.

This technical market research report contributes to the areas of market growth in circulating tumor cells and diagnostic strategies for metastatic cancer. As such, it will be of interest largely to the pharmaceutical and biotechnology industries, as well as clinics, hospitals, and research institutes. In addition, this report will prove crucial for investment firms looking for opportunities in this market.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES